Liquidia Shares Plunge After Court Rules Against Lung Drug Patent
Liquidia's shares dropped nearly 50% after a federal judge ruled that its lung drug infringes a key patent held by United Therapeutics, significantly impacting the drug's commercial prospects.
Story updates
07:46:46 PM UTC
SquawkNews
United Therapeutics (UTHR) shares jumped about 13% Wednesday, and Liquidia (LQDA) plunged as much as 57% after a Delaware judge found that Liquidia’s Yutrepia infringes two claims of a United Therapeutics patent on inhaled treatment of pulmonary hypertension associated with interstitial lung diseas…
Liquidia NASDAQ:LQDA shares plunged nearly 50% on Wednesday after a federal judge ruled that its lung drug infringes a key patent held by rival United Therapeutics NASDAQ:UTHR, dealing a major blow to the treatment’s commercial outlook. The US District Court for the District of Delaware found that Liq…